Key information relating to the preferential rights issue to be carried out by poLight ASA
Reference is made to the stock exchange announcement published poLight ASA (the "Company" or "poLight") on 20 March 2023 regarding the contemplated partly underwritten rights issue in the Company, to raise gross proceeds of up to NOK 135 million (the "Rights Issue") and to the updated proposals form the Company's Board of Directors announced on 11 April 2023 as well as the increased underwriting amount for the Rights Issue. Updated key information relating to the Rights Issue is set out below.
Date on which the terms and conditions of the Rights Issue were announced: 20 March 2023
Last day including right: 11 April 2023
Ex-date: 12 April 2023
Record Date: 13 April 2023
Date of approval: 11 April 2023
Number of new shares: 12,918,660
Subscription price: NOK 10.45
Ratio subscription rights: 0.248661 subscription right per 1 existing share in the Company. The aggregate number of subscription rights granted to each shareholder will be rounded down to the nearest whole subscription right.
Subscription ratio: 1:1 (1 subscription right will give the right to subscribe 1 new share in the Rights Issue)
Manager: Pareto Securities AS
Will the rights be listed: Yes
ISIN for the subscription rights: NO 001 2888215
Other information: The Rights Issue is fully underwritten. The Rights Issue is subject to approval by the Company's extraordinary general meeting (the "EGM") to be held today, 11 April 2023, at 18:00 hours (CEST). Please refer to the notice for the EGM for further information about the Rights Issue, published by the Company on 20 March 2023 and available on https://www.polight.com/investors/general-meetings/default.aspx, as well as information relating to determination of the subscription price, the number of shares in the Rights Issue and the increased underwriting amount, published by the Company earlier today on 11 April 2023.
For additional information, please contact:
Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 9
About poLight ASA:
poLight offers a new autofocus lens which "replicates" the human eye for use in devices such as smartphones, wearables, barcode, machine vision systems and various medical equipment. poLight's TLens® enables better system performance and new user experiences due to benefits such as extremely fast focus, small footprint, no magnetic interference, low power consumption and constant field of view. poLight is based in Horten, Norway, with employees in Finland, France, UK, US, China, Taiwan and Philippines. For more information, please visit https://www.polight.com
This information is published in accordance with the requirements of the Continuing Obligations.